Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression.
ABSTRACT Polymorphisms in the promoter region of the serotonin transporter gene (5-HTTLPR) influence transcription and may play a role in the pathogenesis and course of depression. Recent research demonstrates that specific polymorphisms may be associated with differences in hippocampal volumes in subjects with depression.
To examine associations between 5-HTTLPR genotype and hippocampal volumes in elderly control subjects and elderly subjects classified as having early or late onset of depression.
Cohort study examining baseline characteristics.
Subjects were community dwelling and 60 years or older. Using a definition of early-onset depression as depression first occurring at 50 years or younger, we examined 72 subjects with early-onset depression, 63 subjects with late-onset depression, and 83 healthy control subjects.
All subjects underwent genotyping for the 5-HTTLPR and underwent brain magnetic resonance imaging. Analyses of hippocampal volumes were controlled for total cerebral volume, age, and sex.
The interaction between diagnosis and 5-HTTLPR genotype was statistically significant for the right hippocampus (P = .04). Subjects with late-onset depression who were homozygous for the long (L) allele (L /L genotype) had significantly smaller right hippocampal volumes than did L /L subjects with early-onset depression (P = .046) or L /L control subjects (P = .01). Post hoc analyses showed that later age of depression onset was associated with smaller hippocampal volumes in subjects with the L /L genotype, but earlier age of onset was associated with smaller hippocampal volumes in subjects who were homozygous for the short (S) allele (S/S genotype).
Subjects with late-onset depression who were homozygous for the L allele exhibited smaller hippocampal volumes than other groups. Genotype also mediated the effect of age of onset on hippocampal volumes. Our findings differ from previous work; however, we examined an older and larger cohort of subjects than previous studies. Possible explanations for these findings include interactions between the serotonergic system and neurotrophic factors or cortisol response to stresses, each of which may affect hippocampal volumes.
Full-textDOI: · Available from: Warren Taylor, Dec 16, 2014
[Show abstract] [Hide abstract]
ABSTRACT: Rice blast, caused by Magnaporthe oryzae, became more severe in Heilongjiang Province, China during the past few years. The objectives of this study were to understand the race and virulence gene compositions of local M. oryzae populations, and purposefully select blast resistance genes for efficient development and deployment of resistant rice cultivars. A total of 173 isolates, collected from different rice-cropping districts of the province in 2006, were tested for their pathogenicity against 9 Japanese and 7 Chinese differential varieties (DVs) together with 31 rice monogenic lines (MLs) with different blast resistance genes and 12 local leading cultivars. Out of these 173 isolates, 55 Japanese pathotypes were identified using the Japanese DVs, and the predominant races were 017, 077, 037, 377, and 047, which accounted for 38.15% of all isolates tested. The comparison of differential ability between Japanese and Chinese DVs testified that the former one was much more suitable for M. oryzae pathotyping in Heilongjiang Province. Among the 12 leading cultivars tested, only Longjing 14 and Longdun 104 still kept good resistance to blast disease. The resistance gene Pi9 showed the broadest resistance spectrum (on average 94.80%) to all the blast isolates tested, and was of the highest utilization value in rice blast resistance breeding. The resistance genes Pi-z5(CA), Pi-z5(R), Pi-ta2(R), Pi-ta2(P), Pi-12(t), and Pi20(t) also showed high utilization values due to their resistance spectra of around 70%. The most effective breeding strategy for blast resistance should be as follows: 1) to use rationally Longjing 14, Longdun 104, and Pi9 as resistance donors, and pyramid one to several broad-spectrum resistance genes into elite leading cultivars by means of marker-assisted selection; 2) to strengthen monitoring of predominant virulent races and their temporal and spatial variation; and 3) to explore new resistance resources extensively and transfer the new broad-spectrum resistance genes into leading cultivars purposefully.ACTA AGRONOMICA SINICA 01/2011; 37(1):18-27. DOI:10.3724/SP.J.1006.2011.00018
[Show abstract] [Hide abstract]
ABSTRACT: Major psychiatric disorders such as schizophrenia, major depressive and bipolar disorders are severe, chronic and debilitating, and are associated with high disease burden and healthcare costs. Currently, diagnoses of these disorders rely on interview-based assessments of subjective self-reported symptoms. Early diagnosis is difficult, misdiagnosis is a frequent occurrence and there are no objective tests that aid in the prediction of individual responses to treatment. Consequently, validated biomarkers are urgently needed to help address these unmet clinical needs. Historically, psychiatric disorders are viewed as brain disorders and consequently only a few researchers have as yet evaluated systemic changes in psychiatric patients. However, promising research has begun to challenge this concept and there is an increasing awareness that disease-related changes can be traced in the peripheral system which may even be involved in the precipitation of disease onset and course. Converging evidence from molecular profiling analysis of blood serum/plasma have revealed robust molecular changes in psychiatric patients, suggesting that these disorders may be detectable in other systems of the body such as the circulating blood. In this review, we discuss the current clinical needs in psychiatry, highlight the importance of biomarkers in the field, and review a representative selection of biomarker studies to highlight opportunities for the implementation of personalized medicine approaches in the field of psychiatry. It is anticipated that the implementation of validated biomarker tests will not only improve the diagnosis and more effective treatment of psychiatric patients, but also improve prognosis and disease outcome.Progress in Neurobiology 11/2014; 122. DOI:10.1016/j.pneurobio.2014.08.002 · 10.30 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: The extent to which brain structural abnormalities might serve as neurobiological endophenotypes that mediate the link between the variation in the promoter of the serotonin transporter gene (5-HTTLPR) and depression is currently unknown. We therefore investigated whether variation in hippocampus, amygdala, orbitofrontal cortex (OFC) and anterior cingulate cortex volumes at age 12 years mediated a putative association between 5-HTTLPR genotype and first onset of major depressive disorder (MDD) between age 13–19 years, in a longitudinal study of 174 adolescents (48% males). Increasing copies of S-alleles were found to predict smaller left hippocampal volume, which in turn was associated with increased risk of experiencing a first onset of MDD. Increasing copies of S-alleles also predicted both smaller left and right medial OFC volumes, although neither left nor right medial OFC volumes were prospectively associated with a first episode of MDD during adolescence. The findings therefore suggest that structural abnormalities in the left hippocampus may be present prior to the onset of depression during adolescence and may be partly responsible for an indirect association between 5-HTTLPR genotype and depressive illness. 5-HTTLPR genotype may also impact upon other regions of the brain, such as the OFC, but structural differences in these regions in early adolescence may not necessarily alter the risk for onset of depression during later adolescence. Translational Psychiatry (2014) 4, e445; doi:10.1038/tp.Translational Psychiatry 09/2014; DOI:10.1038/tp.2014.85 · 4.36 Impact Factor